The Periphery of Salivary Gland Carcinoma Tumors Reveals a PD-L1/PD-1 Biomarker Niche for the Evaluation of Disease Severity and Tumor—Immune System Interplay

The treatment options for patients with advanced salivary gland cancers (SGCs) are limited. Immune checkpoint inhibitors (ICIs) have revolutionized cancer treatment. However, the response to ICI immunotherapy is largely driven by the immune cell signatures within the tumor tissue and the para-tumora...

Descripción completa

Detalles Bibliográficos
Autores principales: Kuchar, Martin, Strizova, Zuzana, Capkova, Linda, Komarc, Martin, Skrivan, Jiri, Bartunkova, Jirina, Smrz, Daniel, Plzak, Jan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7909271/
https://www.ncbi.nlm.nih.gov/pubmed/33498270
http://dx.doi.org/10.3390/biomedicines9020097

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7909271/
https://www.ncbi.nlm.nih.gov/pubmed/33498270
http://dx.doi.org/10.3390/biomedicines9020097

Ejemplares similares